Oxaliplatin is a platinum-based antineoplastic agent belonging to the organoplatinum complex class, primarily utilized in combination therapies for the treatment of advanced colorectal and other malignancies.… Read more


![Chemical structure of [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,Κn') Diiodoplatinum](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F66845-32-7-SP-4-2-1R-trans-12-Cyclohexanediamine-Nn-Diiodoplatinum.png&w=3840&q=75)



![Chemical structure of Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dinitrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F94042-08-7-Diaquo1R2R-12-cyclohexanediamineplatinum-Dinitrate.png&w=3840&q=75)










![Chemical structure of Platinum, [rel-(1R,2S)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-, (SP-4-3)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2048922-71-8-Platinum-rel-1R2S-12-cyclohexanediamine-N1N2ethanedioato2-O1O2-SP-4-3.png&w=3840&q=75)
Oxaliplatin is a platinum-based antineoplastic agent belonging to the organoplatinum complex class, primarily utilized in combination therapies for the treatment of advanced colorectal and other malignancies. This cytotoxic agent functions by forming DNA adducts, which inhibits DNA replication and transcription to effectively halt tumor cell growth. To support rigorous pharmaceutical quality control, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient and its associated impurities. These materials are essential for accurate impurity profiling, system suitability testing, and method validation during drug development. Additionally, the availability of stable isotope labelled compounds allows for precise, reliable quantitative analysis in complex analytical matrices. By utilizing these materials, laboratories can effectively monitor degradation products and related compounds, ensuring ongoing compliance with regulatory requirements throughout the manufacturing and stability testing of the drug product.